ATE530666T1 - Mikrobläschen zur affinitätstrennung - Google Patents

Mikrobläschen zur affinitätstrennung

Info

Publication number
ATE530666T1
ATE530666T1 AT05858304T AT05858304T ATE530666T1 AT E530666 T1 ATE530666 T1 AT E530666T1 AT 05858304 T AT05858304 T AT 05858304T AT 05858304 T AT05858304 T AT 05858304T AT E530666 T1 ATE530666 T1 AT E530666T1
Authority
AT
Austria
Prior art keywords
microbubbles
affinity
affinity separation
methods
coated
Prior art date
Application number
AT05858304T
Other languages
English (en)
Inventor
Thomas Adams
Edward Jablonski
Original Assignee
Iris Molecular Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iris Molecular Diagnostics Inc filed Critical Iris Molecular Diagnostics Inc
Application granted granted Critical
Publication of ATE530666T1 publication Critical patent/ATE530666T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/545—Synthetic resin
    • G01N33/546—Synthetic resin as water suspendable particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/545—Synthetic resin
    • G01N33/547—Synthetic resin with antigen or antibody attached to the carrier via a bridging agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/552—Glass or silica
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
    • G01N2333/765—Serum albumin, e.g. HSA
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Inorganic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT05858304T 2004-11-03 2005-11-03 Mikrobläschen zur affinitätstrennung ATE530666T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62494804P 2004-11-03 2004-11-03
PCT/US2005/040162 WO2006137933A2 (en) 2004-11-03 2005-11-03 Microbubbles for affinity separation

Publications (1)

Publication Number Publication Date
ATE530666T1 true ATE530666T1 (de) 2011-11-15

Family

ID=37570908

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05858304T ATE530666T1 (de) 2004-11-03 2005-11-03 Mikrobläschen zur affinitätstrennung

Country Status (12)

Country Link
US (3) US8835186B2 (de)
EP (2) EP2302078B1 (de)
JP (2) JP5037350B2 (de)
KR (1) KR101281433B1 (de)
CN (2) CN101065497B (de)
AT (1) ATE530666T1 (de)
AU (1) AU2005333157B2 (de)
CA (1) CA2585675A1 (de)
DK (1) DK1815028T3 (de)
ES (2) ES2550177T3 (de)
PT (1) PT1815028E (de)
WO (1) WO2006137933A2 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5188808B2 (ja) 2004-11-03 2013-04-24 アイリス モレキュラー ダイアグノスティクス， インコーポレイテッド 同種の分析物検出
CA2585675A1 (en) 2004-11-03 2006-12-28 Iris Molecular Diagnostics, Inc. Microbubbles for affinity separation
WO2012161226A1 (ja) * 2011-05-23 2012-11-29 積水メディカル株式会社 Pivka-ii測定試薬における非特異反応の抑制方法
IN2014CN04433A (de) 2011-12-21 2015-09-04 3M Innovative Properties Co
KR101462986B1 (ko) 2012-06-25 2014-11-19 대한민국 분변 중 요네균 신속분리를 위한 자석 나노입자를 이용한 검출방법
US20140288421A1 (en) * 2013-03-12 2014-09-25 The Regents Of The University Of California Gas vesicle ultrasound contrast agents and methods of using the same
AU2014232882B2 (en) 2013-03-15 2018-03-22 Hycor Biomedical, Inc. Automated immunoanalyzer system for performing diagnostic assays for allergies and autoimmune diseases
US20150219636A1 (en) 2014-01-28 2015-08-06 Targeson, Inc. Isolation of cells and biological substances using buoyant microbubbles
JP6557681B2 (ja) * 2014-05-10 2019-08-07 ダイアグノロジックス・エルエルシー 浮力を用いて薬剤を単離または濃縮するためのシステムおよび装置
US11291931B2 (en) * 2014-12-15 2022-04-05 Akadeum Life Sciences, Inc. Method and system for buoyant separation
US10195547B2 (en) 2014-12-15 2019-02-05 Akadeum Life Sciences, Inc. Method and system for buoyant separation
WO2016179053A1 (en) 2015-05-01 2016-11-10 BioLegend, Inc. Stable nanomagnetic particle dispersions
RU2018107453A (ru) 2015-08-10 2019-09-12 Эссенликс Корп. Устройства для анализов и способы в биологии/химии, предусматривающие упрощенные стадии, образцы небольшого объема, повышенную скорость и простоту применения
KR101982330B1 (ko) 2015-09-14 2019-05-24 에센릭스 코프. 증기 응축액 특히 입김 응축액을 수집 및 분석하기 위한 장치 및 시스템 그리고 이 장치 및 시스템을 사용하는 방법
CN112462055B (zh) 2015-09-14 2024-06-07 上海宜晟生物科技有限公司 用于分析样品，尤其是血液，的装置和系统以及其使用方法
CA2989898C (en) * 2015-12-29 2024-01-16 Thermogenesis Corporation Cell separation devices, systems, and methods
US20190127697A1 (en) 2016-04-30 2019-05-02 BioLegend, Inc. Compositions and methods for performing magnetibuoyant separations
EP3523628B1 (de) * 2016-10-06 2023-02-22 Iris International, Inc. System und verfahren für dynamischen fokus
AU2017378413B2 (en) * 2016-12-16 2024-02-01 Diagnologix, Llc Buoyancy enabled separation method and system
EP3558121B1 (de) 2016-12-21 2022-06-08 Essenlix Corporation Vorrichtungen und verfahren zur authentifizierung einer probe und verwendung davon
WO2018148342A1 (en) 2017-02-07 2018-08-16 Essenlix Corporation Compressed open flow assay and use
CA3053002A1 (en) 2017-02-08 2018-08-16 Essenlix Corp. Bio/chemical material extraction and assay
US12066434B2 (en) 2017-02-08 2024-08-20 Essenlix Corporation QMAX assays and applications
CA3053005A1 (en) 2017-02-08 2018-08-16 Essenlix Corporation Sample collection and handling for delayed analysis
CN111433606B (zh) 2017-02-09 2024-05-24 上海宜晟生物科技有限公司 采用不同间距高度的测定
CN110998325B (zh) 2017-02-09 2024-08-16 上海宜晟生物科技有限公司 扩增测定
EP3662259A4 (de) 2017-02-09 2021-08-25 Essenlix Corporation Kolorimetrische tests
US10966634B2 (en) 2017-02-16 2021-04-06 Essenlix Corporation Assay with textured surface
US11280706B2 (en) 2017-08-01 2022-03-22 Essenlix Corporation Dilution calibration
CN112689758A (zh) 2017-08-01 2021-04-20 Essenlix公司 检查药物对微生物影响的装置和方法
US11243201B2 (en) 2017-08-01 2022-02-08 Essenlix Corporation Sample collection, holding and assaying
WO2019075415A1 (en) 2017-10-13 2019-04-18 Essenlix Corporation DEVICES AND METHODS FOR AUTHENTICATING MEDICAL ANALYSIS AND USES THEREOF
US11237113B2 (en) 2017-10-26 2022-02-01 Essenlix Corporation Rapid pH measurement
US11609224B2 (en) 2017-10-26 2023-03-21 Essenlix Corporation Devices and methods for white blood cell analyses
US10807095B2 (en) 2017-10-26 2020-10-20 Essenlix Corporation Making and tracking assay card
US11648551B2 (en) 2017-12-12 2023-05-16 Essenlix Corporation Sample manipulation and assay with rapid temperature change
WO2019118936A2 (en) 2017-12-14 2019-06-20 Essenlix Corporation Devices, systems, and methods for monitoring hair
WO2019140334A1 (en) 2018-01-11 2019-07-18 Essenlix Corporation Homogeneous assay (ii)
CN111902720A (zh) 2018-03-21 2020-11-06 沃特世科技公司 基于非抗体高亲和力的样品制备、吸附剂、装置和方法
WO2019204506A1 (en) 2018-04-17 2019-10-24 California Institute Of Technology Cross amplitude modulation ultrasound pulse sequence
WO2020014273A1 (en) 2018-07-09 2020-01-16 Akadeum Life Sciences, Inc. System and method for buoyant particle processing
US11885952B2 (en) 2018-07-30 2024-01-30 Essenlix Corporation Optics, device, and system for assaying and imaging
CN109608679B (zh) * 2018-12-10 2021-09-21 天津工业大学 一种核孔复合体接枝聚合物仿生膜制备方法
CN110354523B (zh) * 2019-07-14 2024-02-06 河北龙亿环境工程有限公司 一种具有多微孔气泡罩的新型塔板
WO2021059195A1 (en) * 2019-09-26 2021-04-01 3M Innovative Properties Company Compositions and methods of detecting analytes
EP4392158A1 (de) 2021-08-26 2024-07-03 Akadeum Life Sciences, Inc. Verfahren und system zur schwimmenden trennung
EP4399323A1 (de) * 2021-09-07 2024-07-17 Triangle Biotechnology, Inc. Gezielte nanotropfen- und mikrobläschenzusammensetzungen und verfahren zur anreicherung, lyse und extraktion mikrobieller zellen
WO2024173590A1 (en) 2023-02-14 2024-08-22 Akadeum Life Sciences, Inc. Method and system for partially or fully automated buoyancy-assisted separation

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582956A (en) * 1976-07-30 1981-01-21 Ici Ltd Composite magnetic particles
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
DE3100535A1 (de) 1981-01-10 1982-08-12 Dr. Karl Thomae Gmbh, 7950 Biberach "neue carbonsaeure-derivate, ihre herstellung und ihre verwendung als arzneimittel"
FR2571498B1 (fr) * 1984-10-04 1988-04-08 Immunotech Sa Procede de separation de cellules utilisant des anticorps et des billes de faible densite
US4618525A (en) * 1985-06-03 1986-10-21 Minnesota Mining And Manufacturing Company Coated glass microbubbles and article incorporating them
US4824776A (en) * 1985-07-25 1989-04-25 Molecular Biosystems, Inc. Method for increasing the sensitivity of nucleic acid hybridization assays
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4933447A (en) * 1987-09-24 1990-06-12 Ss Pharmaceutical Co., Ltd. Quinoline derivatives
US4957656A (en) * 1988-09-14 1990-09-18 Molecular Biosystems, Inc. Continuous sonication method for preparing protein encapsulated microbubbles
US5766849A (en) * 1989-07-11 1998-06-16 Gen-Probe Incorporated Methods of amplifying nucleic acids using promoter-containing primer sequence
SE9002480D0 (sv) * 1990-07-23 1990-07-23 Hans Lilja Assay of free and complexed prostate-specific antigen
EP0488152A3 (en) 1990-11-30 1992-11-25 Hitachi, Ltd. Method for immunoassay and apparatus therefor
WO1992015708A1 (en) * 1991-02-27 1992-09-17 Amoco Corporation Methods for improving the sensitivity of hybridization assays
IE920778A1 (en) 1991-03-12 1992-09-23 Du Pont Method for specific binding assays using a releasable ligand
US5665539A (en) * 1991-07-12 1997-09-09 The Regents Of The University Of California Immuno-polymerase chain reaction system for antigen detection
US6723303B1 (en) * 1991-09-17 2004-04-20 Amersham Health, As Ultrasound contrast agents including protein stabilized microspheres of perfluoropropane, perfluorobutane or perfluoropentane
EP1331011A3 (de) 1991-10-24 2003-12-17 Isis Pharmaceuticals, Inc. Derivatisierte Oligonukleotide mit verbessertem Aufnahmevermögen.
US5270184A (en) * 1991-11-19 1993-12-14 Becton, Dickinson And Company Nucleic acid target generation
US6172208B1 (en) * 1992-07-06 2001-01-09 Genzyme Corporation Oligonucleotides modified with conjugate groups
DE4232755A1 (de) 1992-09-26 1994-03-31 Schering Ag Mikropartikelpräparationen aus biologisch abbaubaren Mischpolymeren
EP0688366B1 (de) * 1993-01-15 2002-05-22 The Public Health Research Institute Of The City Of New York, Inc. Empfindlicher nukleinsäure-sandwichhybridisierungs-assay und kits
US5985548A (en) * 1993-02-04 1999-11-16 E. I. Du Pont De Nemours And Company Amplification of assay reporters by nucleic acid replication
DE69432897T2 (de) * 1993-05-10 2004-05-27 Nissui Pharmaceutical Co., Ltd. Verfahren zur bestimmung von mehr als einem immunologischen liganden und bestimmungsreagenz sowie satz dafuer
US5635602A (en) * 1993-08-13 1997-06-03 The Regents Of The University Of California Design and synthesis of bispecific DNA-antibody conjugates
US5599677A (en) * 1993-12-29 1997-02-04 Abbott Laboratories Immunoassays for prostate specific antigen
US5648213A (en) * 1994-08-30 1997-07-15 Beckman Instruments, Inc. Compositions and methods for use in detection of analytes
JPH08178926A (ja) * 1994-10-25 1996-07-12 Sumitomo Pharmaceut Co Ltd イムノアッセイプレートおよびその用途
CN1046520C (zh) 1994-11-15 1999-11-17 法玛西雅厄普约翰美国公司 二环噁嗪及噻嗪噁唑烷酮抗菌剂
SE504798C2 (sv) 1995-06-16 1997-04-28 Ulf Landegren Immunanalys och testkit med två reagens som kan tvärbindas om de adsorberats till analyten
DE19524133A1 (de) * 1995-07-03 1997-01-09 Bayer Ag Die Verwendung von neuen und bekannten kationischen 4,5-Dihydro-1H-1,2,3-triazoliumverbindungen als Farbstoffe, neue kationische 4,5-Dihydro-1H-1,2,3-triazoliumverbindungen und deren Herstellung
NO301198B1 (no) 1995-07-14 1997-09-22 Alcatel Kabel Norge As Kabel, fremgangsmåte og impregneringsmasse
AT403803B (de) 1996-04-19 1998-05-25 Sanochemia Ltd Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
US6165942A (en) 1996-10-03 2000-12-26 Nissan Chemical Industries, Ltd. Heterocycle-fused pyrimidinone derivative and herbicidal composition
US6083484A (en) * 1996-10-17 2000-07-04 Molecular Biosystems, Inc. Microparticles stabilized by polynuclear chromium complexes and their use as ultrasound contrast agents
US6245318B1 (en) 1997-05-27 2001-06-12 Mallinckrodt Inc. Selectively binding ultrasound contrast agents
US6086540A (en) * 1997-10-07 2000-07-11 Molecular Biosystems, Inc. Methods of ultrasound imaging using echogenically persistent contrast agents
US6531278B1 (en) * 1998-01-14 2003-03-11 Utah State University Ligand-DNA composition for capture and detection of contaminants on a solid surface
CA2326386A1 (en) * 1998-04-28 1999-11-04 Nycomed Imaging As Improvements in or relating to separation processes
US8063190B2 (en) * 1998-06-02 2011-11-22 Tom Robin Caine Boyde Nucleic acid-linked conjugates and methods for making and using them
US6214566B1 (en) * 1998-11-16 2001-04-10 The Administrators Of The Tulane Educational Fund Method for detecting anti-squalene antibodies
WO2000041524A2 (en) 1999-01-11 2000-07-20 President And Fellows Of Harvard College Isothermal amplification of dna
WO2001027630A2 (en) * 1999-10-13 2001-04-19 The University Of British Columbia Methods to identify compounds that modulate neuronal activity
CA2391534A1 (en) * 1999-11-15 2001-05-25 Drug Innovation & Design, Inc. Selective cellular targeting: multifunctional delivery vehicles
US7306904B2 (en) * 2000-02-18 2007-12-11 Olink Ab Methods and kits for proximity probing
US6511809B2 (en) * 2000-06-13 2003-01-28 E. I. Du Pont De Nemours And Company Method for the detection of an analyte by means of a nucleic acid reporter
US7439016B1 (en) 2000-06-15 2008-10-21 Digene Corporation Detection of nucleic acids by type-specific hybrid capture method
US20020132260A1 (en) 2001-02-22 2002-09-19 Erlander Mark G. Quantitative immunohistochemistry (QIHC)
WO2002083951A1 (en) 2001-04-10 2002-10-24 Northeastern University Multiplexed ligand/protein binding assays with pna labels
EP1249500A1 (de) 2001-04-12 2002-10-16 chimera biotec GmbH Verfahren zum Nachweis einer Substanz
WO2003011824A1 (en) 2001-07-31 2003-02-13 Bristol-Myers Squibb Company Bicyclic modulators of androgen receptor function
US20060154246A1 (en) 2002-03-08 2006-07-13 Dario Neri Encoded self-assembling chemical libraries (esachel)
CA2965865C (en) * 2002-07-18 2021-10-19 Merus N.V. Recombinant production of mixtures of antibodies
BR0313405A (pt) 2002-08-12 2005-07-12 Takeda Pharmaceutical Compostos, métodos para preparar um composto e para prevenir e/ou tratar câncer, prodroga, medicamento, modulador do receptor de androgênio, agente para prevenir e/ou tratar hipogonadismo ou pertubação climatérica masculina, osteoporose e câncer, e, uso de um composto
DK1563100T3 (da) * 2002-11-01 2013-08-05 Iris Int Inc Fortrængningssandwich-immuno-PCR
US20090176207A1 (en) * 2004-06-23 2009-07-09 Washington University Methods for Determining Risk of Developing Regular Smoking Behavior
CN101084207A (zh) 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其作为硬脂酰CoA去饱和酶抑制剂的用途
CA2585675A1 (en) 2004-11-03 2006-12-28 Iris Molecular Diagnostics, Inc. Microbubbles for affinity separation
JP5188808B2 (ja) * 2004-11-03 2013-04-24 アイリス モレキュラー ダイアグノスティクス， インコーポレイテッド 同種の分析物検出
ES2433745T3 (es) 2008-02-21 2013-12-12 Iris International, Inc. Procedimiento para la determinación temprana de recidivas tras la terapia para el cáncer de próstata

Also Published As

Publication number Publication date
JP2008518973A (ja) 2008-06-05
EP1815028A4 (de) 2008-09-10
EP2302078B1 (de) 2015-07-15
KR20070110484A (ko) 2007-11-19
DK1815028T3 (da) 2012-01-30
US20110230644A1 (en) 2011-09-22
ES2376578T3 (es) 2012-03-15
JP5037350B2 (ja) 2012-09-26
WO2006137933A2 (en) 2006-12-28
EP2302078A1 (de) 2011-03-30
ES2550177T3 (es) 2015-11-05
CN101065497A (zh) 2007-10-31
CA2585675A1 (en) 2006-12-28
AU2005333157A1 (en) 2006-12-28
US8513032B2 (en) 2013-08-20
CN103091485A (zh) 2013-05-08
US20090176201A1 (en) 2009-07-09
PT1815028E (pt) 2012-01-24
WO2006137933A3 (en) 2007-05-03
EP1815028A2 (de) 2007-08-08
EP1815028B1 (de) 2011-10-26
US8835186B2 (en) 2014-09-16
US20110236884A1 (en) 2011-09-29
AU2005333157B2 (en) 2011-06-30
CN101065497B (zh) 2012-11-21
KR101281433B1 (ko) 2013-07-02
JP2012197281A (ja) 2012-10-18

Similar Documents

Publication Publication Date Title
ATE530666T1 (de) Mikrobläschen zur affinitätstrennung
DE60230672D1 (de) Nukleinsäureanreicherung
WO2007098184A3 (en) Methods and compositions for analyte detection
ATE515702T1 (de) Verfahren, mixturen, kits und zusammensetzungen bezüglich der analytbestimmung
WO2006105152A3 (en) Amnion-derived cell compositions, methods of making and uses thereof
EA200700094A1 (ru) Способ промышленной очистки образцов клеток для получения терапевтических протеинов
ATE419629T1 (de) Poröse ferro- oder ferrimagnetische glasteilchen für molekültrennung
NO20043245L (no) Bindingsproteiner som biosensorer
WO2007100506A3 (en) Mass tags for quantitative analyses
WO2007070381A3 (en) Nucleic acid purification with a binding matrix
WO2005085869A3 (en) Determination of analyte characteristics based upon binding properties
ES2422583T3 (es) Detección de parvovirus B19
ATE449186T1 (de) Zusammensetzungen und verfahren zur selektiven nukleinsäureisolierung
WO2006052419A3 (en) Nucleic acid enzyme light-up sensor utilizing invasive dna
WO2006119107A3 (en) Sclerostin binding agents
WO2006119062A3 (en) Sclerostin epitopes
WO2008085962A3 (en) Cell culture methods for producing recombinant proteins in the presence of reduced levels of one or more contaminants
WO2006076687A3 (en) Elisa assays using prion-specific peptide reagents
ATE466080T1 (de) Formulierungen und verfahren zum denaturieren von proteinen
ATE483018T1 (de) Neue fluoreszenzproteine und verfahren zur verwendung davon
DE602005000249D1 (de) Verfahren zur Isolierung von Bakterien aus biologischen Proben
ATE497779T1 (de) Enzyme zur reduzierung von immunologischem stress
HK1099074A1 (en) Purification methods and uses thereof
WO2007056047A3 (en) Antibodies, assays and kits to quantitate cartilage destruction
ATE383418T1 (de) Verfahren und zusammensetzungen zur bestimmung glycierter proteine

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1815028

Country of ref document: EP